A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo
NCT02644135
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Halo Oral Spray
DRUG:
Halo Placebo
Sponsor
University Hospitals Cleveland Medical Center